Marengo Therapeutics Inc

Marengo Therapeutics, Inc. operates as a biotechnology company. The Company develops novel TCR-targeting antibodies that selectively modulate common and disease specific T cell subsets to combat cancer and other diseases. Marengo Therapeutics serves customers in the United States.